An international comparison of retinopathy of prematurity grading performance within the Benefits of Oxygen Saturation Targeting II trials.

<h4>Purpose</h4> <p>To investigate whether the observed international differences in retinopathy of prematurity (ROP) treatment rates within the Benefits of Oxygen Saturation Targeting (BOOST) II trials might have been caused by international variation in ROP disease grading.</...

Full description

Bibliographic Details
Main Authors: Fleck, B, Williams, C, Juszczak, E, Cocker, K, Stenson, B, Darlow, B, Dai, S, Gole, G, Quinn, G, Wallace, D, Ells, A, Carden, S, Butler, L, Clark, D, Elder, J, Wilson, C, Biswas, S, Shafiq, A, King, A, Brocklehurst, P, Fielder, A
Format: Journal article
Language:English
Published: Nature Publishing Group 2017